167 related articles for article (PubMed ID: 33842320)
1. Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.
Feng Y; Liu Y; Zhong M; Wang L
Front Oncol; 2021; 11():618694. PubMed ID: 33842320
[TBL] [Abstract][Full Text] [Related]
2. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
3. A Risk Model Composed of Complete Blood Count,
Wang L; Yuan L; Du X; Zhou K; Yang Y; Qin Q; Yang L; Xiang Y; Qu X; Liu H; Qin X; Liu C
Front Oncol; 2022; 12():800786. PubMed ID: 35186740
[TBL] [Abstract][Full Text] [Related]
4. Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis.
Li S; Xia Z; Cao J; Zhang J; Chen B; Chen T; Zhang X; Zhu W; Li D; Hua W; Mao Y
Front Immunol; 2022; 13():1039862. PubMed ID: 36439151
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.
Luo Q; Yang C; Fu C; Wu W; Wei Y; Zou L
Front Oncol; 2021; 11():639644. PubMed ID: 33996552
[No Abstract] [Full Text] [Related]
6. A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups.
Gao Y; Wei L; Kim SJ; Wang L; He Y; Zheng Y; Bertero L; Pellerino A; Cassoni P; Tamagnone L; Theresa PK; Deutsch A; Zhan H; Lai J; Wang Y; You H
Front Oncol; 2021; 11():696147. PubMed ID: 34422649
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
8. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
Li Q; Yu L; Yang P; Hu Q
Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator.
Matsuda R; Maeoka R; Morimoto T; Nakazawa T; Morisaki Y; Yokoyama S; Kotsugi M; Takeshima Y; Yamada S; Nishimura F; Park YS; Nakagawa I
J Neurooncol; 2024 Apr; ():. PubMed ID: 38658464
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy.
Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S
J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
Shi X; Li H; Xu Y; Nyalali AMK; Li F
Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
[TBL] [Abstract][Full Text] [Related]
14. A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.
Lo YT; Lim VY; Ng M; Tan YH; Chiang J; Chang EWY; Chan JY; Poon EYL; Somasundaram N; Bin Harunal Rashid MF; Tao M; Lim ST; Yang VS
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406590
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma.
Jung J; Lee H; Yun T; Lee E; Moon H; Joo J; Park WS; Choi M; Lee JO; Lee JS; Eom HS
Oncotarget; 2017 Sep; 8(43):74975-74986. PubMed ID: 29088839
[TBL] [Abstract][Full Text] [Related]
16. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
Liu CJ; Lin SY; Yang CF; Yeh CM; Kuan AS; Wang HY; Tsai CK; Gau JP; Hsiao LT; Chen PM; Liu YC; Hong YC; Ko PS; Liu JH; Lin CH
Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis.
Chen Z; Wang K; Lu H; Xue D; Fan M; Zhuang Q; Yin S; He X; Xu R
Cancer Manag Res; 2019; 11():909-919. PubMed ID: 30697081
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy.
Lee S; Oh SY; Kim SH; Lee JH; Kim MC; Kim KH; Kim HJ
BMC Cancer; 2013 Jul; 13():350. PubMed ID: 23876227
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma.
Cho U; Sung YE; Kim MS; Lee YS
Biomedicines; 2022 May; 10(6):. PubMed ID: 35740290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
